Lucia is co-founder and CEO of Osmind, the leading software solution for ketamine clinics and treatment-resistant mental health. Lucia previously worked to help cure ALS and Parkinson’s at Verge Genomics, an AI-driven neuroscience biotech startup. At Verge, she helped scale the company from seed to post-Series A. She previously invested in innovative healthcare technology companies at Warburg Pincus. Lucia started her career advising pharmaceutical companies in investment banking. Lucia graduated Yale with a B.S. in Chemistry and earned an MBA at Stanford Graduate School of Business, where she was also awarded a Certificate in Public Management and Social Innovation. At Stanford, Lucia focused her studies on healthcare and co-led the GSB Healthcare Club. Lucia is passionate about mental health and has devoted her career to improving healthcare, from life sciences to new technology innovation.